Orenitram (treprostinil)

Manufacturer:

United Therapeutics

Route of Administration:

Oral

Site of Care:

Outpatient

Website:

Manufacturer Website

phone:

Enrollment Forms:

Patient Support Form

VA Enrollment Form

Approved Indication:

treatment of pulmonary arterial hypertension (PAH, WHO group 1) to delay disease progression and to improve exercise capacity

Conditions:

Pulmonary Arterial Hypertension